Miguel A. Palacios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miguel A. Palacios has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Frank J. Lagerwaard
Department of Radiation Oncology, VU Medical Center, Amsterdam, The Netherlands
7 shared publications - Omar Bohoudi
Dept. Of Radiation Oncology, VU University Medical Centre, Amsterdam, The Netherlands
7 shared publications Anna M.E. Bruynzeel
Dept. of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
3 shared publicationsBen J. Slotman
Dept. of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
3 shared publicationsS. Senan
3 shared publications- Suresh Senan
Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1117 Amsterdam, The Netherlands
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 3 June 2019
- Published by Springer Nature in Radiation Oncology
- Vol. 14 (1) , 1-12
MR-guidance in clinical reality: current treatment challenges and future perspectives
Magnetic Resonance-guided radiotherapy (MRgRT) marks the beginning of a new era. MR is a versatile and suitable imaging modality for radiotherapy, as it enables direct visualization of the tumor and the surrounding organs at risk. Moreover, MRgRT provides real-time imaging to characterize and eventually track anatomical motion. Nevertheless, the successful translation of new technologies into clinical practice remains challenging. To date, the initial availability of next-generation hybrid MR-linac (MRL) systems is still limited and therefore, the focus of the present preview was on the initial applicability in current clinical practice and on future perspectives of this new technology for different treatment sites. MRgRT can be considered a groundbreaking new technology that is capable of creating new perspectives towards an individualized, patient-oriented planning and treatment approach, especially due to the ability to use daily online adaptation strategies. Furthermore, MRL systems overcome the limitations of conventional image-guided radiotherapy, especially in soft tissue, where target and organs at risk need accurate definition. Nevertheless, some concerns remain regarding the additional time needed to re-optimize dose distributions online, the reliability of the gating and tracking procedures and the interpretation of functional MR imaging markers and their potential changes during the course of treatment. Due to its continuous technological improvement and rapid clinical large-scale application in several anatomical settings, further studies may confirm the potential disruptive role of MRgRT in the evolving oncological environment.
- 3 June 2019
- Published by Springer Nature in Radiation Oncology
- Vol. 14 (1) , 1-12
Top Cited PapersOpen AccessMR-guidance in clinical reality: current treatment challenges and future perspectives
Magnetic Resonance-guided radiotherapy (MRgRT) marks the beginning of a new era. MR is a versatile and suitable imaging modality for radiotherapy, as it enables direct visualization of the tumor and the surrounding organs at risk. Moreover, MRgRT provides real-time imaging to characterize and eventually track anatomical motion. Nevertheless, the successful translation of new technologies into clinical practice remains challenging. To date, the initial availability of next-generation hybrid MR-linac (MRL) systems is still limited and therefore, the focus of the present preview was on the initial applicability in current clinical practice and on future perspectives of this new technology for different treatment sites. MRgRT can be considered a groundbreaking new technology that is capable of creating new perspectives towards an individualized, patient-oriented planning and treatment approach, especially due to the ability to use daily online adaptation strategies. Furthermore, MRL systems overcome the limitations of conventional image-guided radiotherapy, especially in soft tissue, where target and organs at risk need accurate definition. Nevertheless, some concerns remain regarding the additional time needed to re-optimize dose distributions online, the reliability of the gating and tracking procedures and the interpretation of functional MR imaging markers and their potential changes during the course of treatment. Due to its continuous technological improvement and rapid clinical large-scale application in several anatomical settings, further studies may confirm the potential disruptive role of MRgRT in the evolving oncological environment.
- Open Access
- 1 January 2019
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 9, 69-76
Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
- 1 January 2019
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 9, 69-76
Open AccessClinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
- 1 October 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 102 (2) , 426-433
Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases
- 1 October 2018
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 102 (2) , 426-433
Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases
- 11 May 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 127 (3) , 511-512
SBRT for pancreatic cancer: In regard of Bohoudi et al.
- 11 May 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 127 (3) , 511-512
SBRT for pancreatic cancer: In regard of Bohoudi et al.
- Open Access
- 1 April 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 127, S98-S99
OC-0185: SBRT using MR-guided, video-assisted gated treatment delivery during patient breath holds
- 1 April 2018
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 127, S98-S99
Open AccessOC-0185: SBRT using MR-guided, video-assisted gated treatment delivery during patient breath holds
- Top Cited Papers
- 1 December 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 125 (3) , 439-444
Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer
- 1 December 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 125 (3) , 439-444
Top Cited PapersFast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S260-S261
OC-0490: A robust and fast planning approach for adaptive MR-guided treatment of pancreatic cancer
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S260-S261
Open AccessOC-0490: A robust and fast planning approach for adaptive MR-guided treatment of pancreatic cancer
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S134-S135
OC-0262: Implementation of patient specific QA for daily adaptive MR-guided radiation therapy
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S134-S135
Open AccessOC-0262: Implementation of patient specific QA for daily adaptive MR-guided radiation therapy
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S263
SP-0494: Using a MRI-guided radiation therapy system for prostate cancer patients
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S263
Open AccessSP-0494: Using a MRI-guided radiation therapy system for prostate cancer patients
- Open Access
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S505
PO-0912: Short- and long term stability of the isocenter of a three-source Co60 MR guided radiotherapy device
- 1 May 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 123, S505
Open AccessPO-0912: Short- and long term stability of the isocenter of a three-source Co60 MR guided radiotherapy device